— Why it moved
Why CELZ Stock Spiked and Faded Today — August 6, 2026
A patent win gave Creative Medical Technology a temporary boost, but dilution risk and low-float mechanics turned the move into a classic intraday pop and dump.
What moved CELZ stock
Creative Medical Technology Holdings is a micro-cap biotech working on cell-free therapies. The catalyst was a press release announcing a USPTO Notice of Allowance for a patent on their Type 1 diabetes exosome platform. Retail traders jumped on the headline, though a patent allowance is miles away from generating real revenue.
The mechanics
With a tiny float under 3.5 million shares, the stock gapped up nearly 69 percent at the session's start. Day traders traded over 272 million shares, churning the float nearly eighty times over.
CELZ by the numbers
The alert window
The alert triggered at 7:58 AM at $1.26. Anyone following it live had to hold through a 19.8 percent drawdown before the stock finally hit $1.75 at 11:01 AM. That offered a 38.9 percent sellable window over 183 minutes if you survived the early shakeout.
How CELZ's move ended
The volume dried up after midday and the bid collapsed, pulling shares down to close at $1.16 for a 7.9 percent loss from the alert. A recent prospectus filing covering over 5.5 million potential warrant shares left little reason for anyone to hold overnight.
The tell: Micro-cap patent headlines offer short-lived volume spikes, but heavy pre-market drawdowns usually filter out anyone looking for an easy ride.